CA2643736C - Procede et composition pour traiter la mucosite - Google Patents

Procede et composition pour traiter la mucosite Download PDF

Info

Publication number
CA2643736C
CA2643736C CA2643736A CA2643736A CA2643736C CA 2643736 C CA2643736 C CA 2643736C CA 2643736 A CA2643736 A CA 2643736A CA 2643736 A CA2643736 A CA 2643736A CA 2643736 C CA2643736 C CA 2643736C
Authority
CA
Canada
Prior art keywords
peptide
administration
therapy
mucositis
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2643736A
Other languages
English (en)
Other versions
CA2643736A1 (fr
Inventor
F. Gary Toback
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Original Assignee
University of Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05010217A external-priority patent/EP1595547A3/fr
Application filed by University of Chicago filed Critical University of Chicago
Priority claimed from PCT/US2006/018014 external-priority patent/WO2006122162A2/fr
Publication of CA2643736A1 publication Critical patent/CA2643736A1/fr
Application granted granted Critical
Publication of CA2643736C publication Critical patent/CA2643736C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2643736A 2005-05-10 2006-05-09 Procede et composition pour traiter la mucosite Expired - Fee Related CA2643736C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05010217.7 2005-05-10
EP05010217A EP1595547A3 (fr) 2004-05-11 2005-05-10 Utilisation du facteur de croissance AMP pour le traitement des lésions gastrointestinales et de la insuffisance renale aigue
US79017706P 2006-04-07 2006-04-07
US60/790,177 2006-04-07
PCT/US2006/018014 WO2006122162A2 (fr) 2005-05-10 2006-05-09 Procede et composition pour traiter la mucosite

Publications (2)

Publication Number Publication Date
CA2643736A1 CA2643736A1 (fr) 2006-11-16
CA2643736C true CA2643736C (fr) 2015-06-23

Family

ID=40140138

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2643736A Expired - Fee Related CA2643736C (fr) 2005-05-10 2006-05-09 Procede et composition pour traiter la mucosite

Country Status (4)

Country Link
JP (2) JP5058980B2 (fr)
AT (1) ATE526983T1 (fr)
CA (1) CA2643736C (fr)
MX (1) MX2007013982A (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629317B2 (en) * 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
US6734289B2 (en) * 2001-03-29 2004-05-11 The University Of Chicago Gastrokines and derived peptides including inhibitors

Also Published As

Publication number Publication date
CA2643736A1 (fr) 2006-11-16
ATE526983T1 (de) 2011-10-15
JP5058980B2 (ja) 2012-10-24
JP2008544959A (ja) 2008-12-11
MX2007013982A (es) 2008-03-13
JP2012046547A (ja) 2012-03-08

Similar Documents

Publication Publication Date Title
KR102373603B1 (ko) 섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
EP1811033A1 (fr) Inhibiteurs peptidiques à perméabilité cellulaire du processus de transduction du signal de JNK
AU2006244080B2 (en) Use of peptides derived from the growth factor AMP-18 for the treatment of mucositis
JP2008106076A (ja) ＩＩ型ＴＧＦ−βレセプター／免疫グロブリン定常領域融合タンパク質
ES2966133T3 (es) Proteína de fusión que comprende el factor de crecimiento nervioso y método de preparación y uso de la misma
EP1595547A2 (fr) Utilisation du facteur de croissance AMP pour le traitement des lésions gastrointestinales et de la insuffisance renale aigue
US20120148590A1 (en) Cell-permeable peptide inhibitors of the jnk signal transduction pathway
NZ507161A (en) Theraupeutic and diagonistic applications based on the role of the CXCR-4 gene in tumorigenesis
JP2002526073A (ja) 新規のヒト生長分化因子のコード配列、そのｄｎａ配列によりコードされるポリペプチド、およびこれらの製造方法。
ES2700149T3 (es) Proteínas de fusión de UTI
KR20000010571A (ko) 신경교세포주-유래신경영양성인자수용체및이를코드하는핵산서열과아미노산서열_
KR20220097921A (ko) 인터루킨-22의 치료 유도체
KR20170080526A (ko) Fgf21 아날로그, fgf21 결합체, 및 이의 용도
US8017576B2 (en) Methods and compositions to treat mucositis
EP4174088A1 (fr) Protéine de fusion comprenant un anticorps anti-lag-3 et il-2 et son utilisation
US8278269B2 (en) Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
KR102221041B1 (ko) 신증후군 및 관련 병태의 치료 방법
EP1885390B1 (fr) Utilisation des derivees du facteur de croissance amp-18 pour le traitement de la stomatitis
CA2643736C (fr) Procede et composition pour traiter la mucosite
TWI748306B (zh) 包含人類Lefty A蛋白變體的融合蛋白及其用途
WO2012122943A1 (fr) Médicament contre la protéine x du virus de l'hépatite b utlisant un polypeptide
RU2793631C2 (ru) Слитый белок, содержащий варианты человеческого белка lefty а, и его применение
JP2024531823A (ja) ＧＰＣ３標的化抗体インターフェロンα融合タンパク質及びその使用
WO2012142083A2 (fr) Protéine-12 apparentée à c1q/tnf et ses compositions et procédés d'utilisation
KR100399377B1 (ko) Ｇｄｎｆ 단백질의 분석방법 및 검정 기구

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180509